Advertisement

Reactions Weekly

, Volume 1688, Issue 1, pp 35–35 | Cite as

Atezolizumab/nivolumab

Type 1 diabetes mellitus: 2 case reports
Case report
  • 21 Downloads

Reference

  1. Kapke J, et al. Immune checkpoint inhibitor-associated type 1 diabetes mellitus: Case series, review of the literature, and optimal management. Case Reports in Oncology 10: 897-909, No. 3, Sep-Dec 2017. Available from: URL: http://doi.org/10.1159/000480634 - USACrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations